drugset / Trial / NCT00626314

Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System

NCT00626314 ↗

Phase 2 Unknown 165 enrolled Mytogen, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of injecting myoblasts (grown from your own skeletal muscle), using a catheter device, directly into the damaged heart muscle for treatment of severe heart failure.

Timeline

Start
2008-03
Primary completion
2010-03
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject myoblast Cell therapy — Other

Indications